South San Francisco, United States
Calico Life Sciences, founded in 2013, is an innovative Biotechnology and Health Care company headquartered in the United States. The company is at the forefront of advancing research to unlock the biological mechanisms behind human aging, aligning with its mission of enabling healthier, longer lives. With the slogan, "We're tackling aging, one of life's greatest mysteries," Calico seeks to transform theoretical insights into practical healthcare solutions.
As an Alphabet-founded entity, Calico stands out for its cutting-edge technology labs and robust collaborations with both academic and industry partners. This synergy fuels its rich drug-development pipeline, positioning it as a beacon for medical breakthroughs. Its bold approach, emphasizing curiosity-driven discovery, holds significant potential to disrupt age-related therapeutics.
The company most recently secured a Seed Round investment in January 2021 from Backbone Angels. This backing underscores investor confidence in Calico's potential to redefine aging through science.
